Published in Women's Health Weekly, March 22nd, 2001
They report finding a second biologic pathway in monkeys that helps explain birth control pills' protective effect against ovarian cancer.
The results of new laboratory research indicate that the pills' protective effect is not due solely to preventing ovulation, suggesting that chemoprevention of ovarian cancer could be extended to women who are not ovulating or who are not interested in contraception, said Dr. Gustavo Rodriguez. He prepared the study findings for presentation March 4,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.